By Karen Roman
ReAlta Life Sciences, Inc. mentioned it designated Ellen Lubman as Chief Enterprise Officer to oversee enterprise growth, capital formation and company technique.
Ms. Lubman has practically 25 years of expertise throughout small to large-cap personal and public biopharmaceutical corporations with a monitor report in strategic, transactional, and operational roles, the corporate acknowledged. She beforehand served as Chief Enterprise Officer at Werewolf Therapeutics, Inc. (Nasdaq: HOWL), taking the corporate via a number of financings together with an IPO, it mentioned.
“Ellen is a extremely revered govt with a robust monitor report of constructing partnerships, elevating capital, and creating profitable company methods for biotech and pharmaceutical corporations,” mentioned David Marek, ReAlta’s CEO. “We’re excited to welcome Ellen at such a pivotal second for our enterprise with all three medical applications studying out this yr.”
Ms. Lubman holds an M.B.A. from Stanford Graduate College of Enterprise and a B.A. in Biology from Rutgers School.
READ MORE
ReAlta Drug Reveals Promise in Defending New child Brains from Oxygen Deprivation Accidents
By no means Miss our Weekly Highlights HERE
Contact:
Click on HERE to comply with us on LinkedIn
By Karen Roman
ReAlta Life Sciences, Inc. mentioned it designated Ellen Lubman as Chief Enterprise Officer to oversee enterprise growth, capital formation and company technique.
Ms. Lubman has practically 25 years of expertise throughout small to large-cap personal and public biopharmaceutical corporations with a monitor report in strategic, transactional, and operational roles, the corporate acknowledged. She beforehand served as Chief Enterprise Officer at Werewolf Therapeutics, Inc. (Nasdaq: HOWL), taking the corporate via a number of financings together with an IPO, it mentioned.
“Ellen is a extremely revered govt with a robust monitor report of constructing partnerships, elevating capital, and creating profitable company methods for biotech and pharmaceutical corporations,” mentioned David Marek, ReAlta’s CEO. “We’re excited to welcome Ellen at such a pivotal second for our enterprise with all three medical applications studying out this yr.”
Ms. Lubman holds an M.B.A. from Stanford Graduate College of Enterprise and a B.A. in Biology from Rutgers School.
READ MORE
ReAlta Drug Reveals Promise in Defending New child Brains from Oxygen Deprivation Accidents
By no means Miss our Weekly Highlights HERE
Contact:
Click on HERE to comply with us on LinkedIn
